KLOW 80MG
SKU: CP_KLOW_80MG_3ML_VIAL
Catalog price · 1 item: US$158.00 (USD)
Product information
Research background
KLOW combines GHK-Cu, BPC-157, TB-500 and KPV. The page discusses separate-component experiments involving connective-tissue remodeling, tendon cells and inflammatory signaling. GHK-Cu studies measured collagen and matrix accumulation; KPV studies examined particle-exposed keratinocytes and experimental intestinal inflammation. In the cited rat tendon-repair study, some BPC-157 measurements changed, but overall histopathology scores were not statistically different from controls and the authors considered the evidence preliminary.
The page cites no experiment testing the complete four-ingredient blend. Individual-component findings therefore do not establish mixture effects, compatibility or interactions. It restricts the material to laboratory research, recommends sealed storage away from light, and advises matching each vial's batch with its COA.
Specifications
| SKU | CP_KLOW_80MG_3ML_VIAL |
|---|---|
| CATEGORY | Research Compound |
| CAS | BPC-157: 137525-51-0 GHK-CU: 89030-95-5 TB-500: 77591-33-4 KPV: 112965-21-6 |
| VIAL SIZE | 3 mL |
| FORM | LYOPHILIZED POWDER |
| MOLECULAR WEIGHT | N/A |
| COMPOSITION | GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg + KPV 10 mg |
| MOLECULAR FORMULA | N/A |
| ITEM ID | 8855 |
| FORM | LYOPHILIZED POWDER |
| DOSAGE | 80 MG |
| CAS | 89030-95-5 |
| Formula | C14H24CuN6O4 |
| Mol. Wt. | 403.9 g/mol |
| Sequence | Gly-His-Lys coordinated to Cu(II) |
| CAS | 137525-51-0 |
| Formula | C62H98N16O22 |
| Mol. Wt. | 1419.53 g/mol |
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| CAS | 77591-33-4 |
| Formula | C212H350N56O78S |
| Mol. Wt. | 4963.44 g/mol |
| Sequence | SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES (43 aa; LKKTET actin-binding motif, residues 17-22) |
| CAS | 67727-97-3 |
| Formula | C16H30N4O4 |
| Mol. Wt. | 342.43 g/mol |
| Sequence | Lys-Pro-Val (H-Lys-Pro-Val-OH) |